Neogenomics (NEO) Gains from Investment Securities (2010 - 2025)
Neogenomics (NEO) reported Gains from Investment Securities of $5.9 million for Q4 2025, up 1892.95% on a YoY basis from $298000.0 in Q4 2024, and up 1196.72% quarter-over-quarter from $458000.0 in Q2 2025.
Neogenomics (NEO) Gains from Investment Securities (2010 - 2025) Analysis & Trends
Neogenomics has reported Gains from Investment Securities for 16 years, with the latest figure at $5.9 million in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 1892.95% year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 1111.55% YoY), and the FY2025 full-year result was $6.4 million, up 936.79% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $5.9 million, up from $458000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $7.3 million in Q4 2023, with the low at -$49000.0 in Q1 2021.
- Historically, Gains from Investment Securities has averaged $990800.0 across 5 years, with a median of $129000.0 in 2022.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities plunged 2550.0% — and 2023, when it surged 29280.0%.
- Neogenomics' Gains from Investment Securities stood at $35000.0 in 2021, then retreated by 28.57% to $25000.0 in 2022, then surged by 29280.0% to $7.3 million in 2023, then tumbled by 95.94% to $298000.0 in 2024, then soared by 1892.95% to $5.9 million in 2025.
- The last three Gains from Investment Securities figures came in at $5.9 million (Q4 2025), $458000.0 (Q2 2025), and $298000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.94 Mn |
| Dec 31, 2025 | 5.94 Mn |
| Jun 30, 2025 | 458,000.00 |
| Jun 30, 2025 | 458,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 7.35 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Jun 30, 2023 | 175,000.00 |
| Jun 30, 2023 | 175,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Sep 30, 2022 | 26,000.00 |